MarketInOut Stock Screener Log In | Sign Up
 

Palvella Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/17/2026 11:21
Palvella Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,214.57 mln
Float12.74 mln
Earnings Date11/17/2026

1-Year Forecast

231
Exceptional upside

Relative Strength

81 / 100
Strongly outperforming

Debt / Equity

0.10
Very low leverage

ROE

-54.73
Deeply negative

ROA

-42.99
Deeply negative

Business Description

Palvella Therapeutics is a Wayne, Pennsylvania-based medical company working to bring new treatments to people living with rare and serious inherited skin conditions. Its primary focus is a topical gel called QTORIN rapamycin, which is currently being tested in late-stage clinical trials for patients with certain vascular skin disorders. The company is also exploring additional uses of this gel, along with a separate treatment called QTORIN pitavastatin, targeting other hard-to-treat skin diseases.

Key Fundamentals

EPS-4.85
ROE-54.73
ROIC-1,475
ROA-42.99
Interest Cover-7.60
EBITDA, mln-54.10
EV / EBITDA-35.30
EV / EBIT-35.30

Financial Strength

1-Year Target Price231
Short Ratio12.06
Short % of Float17.99

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.6% 86 / 100   
1 Month 3.58% 82 / 100   
2 Months 52.47% 96 / 100   
6 Months 36.4% 88 / 100   
1 Year 186% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us